Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls

American Journal of Gastroenterology

Volumn 91, Issue 5, 1996, Pages 949-953

  Ching, C K ^a   Wong, B C Y ^a   Kwok, E ^a   Ong, L ^a   Covacci, A ^a   Lam, S K ^a  

^a Manning House ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN;

ADULT; ANTIBODY DETECTION; ANTIGEN PRESENTATION; ARTICLE; BACTERIUM DETECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; STOMACH EPITHELIUM; ULCEROGENESIS;

ADULT; ANTIBODIES; COHORT STUDIES; CYTOTOXINS; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0029974653     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tytgat GNJ, Lee A, Graham DY, et al. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993;6:76-89.
2. Davies GR, Crabtree JE. Helicobacter pylori: Trick or treat? J R Soc Med 1994;87:436-9.
3. Goodwin CS. Gastric cancer and Helicobacter pylori: The whispering killer? Lancet 1993;342:507-8.
4. The EuroGast Study Group. An international association between Helicobacler pylori infection and gastric cancer. Lancet 1993;341: 1359-62.
5. Cullen DJE, Collins BJ, Christiansen KJ, et al. Long term risk of peptic ulcer disease in people with Helicobacter pylori infection: A community based study. Gastroenterology 1993;104:A60.
6. Sipponen P, Varis K, Fraki O, et al. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis: A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990;25:966-73.
7. Figura N, Guglielmetti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225-6.
8. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 1991;338:332-5.
9. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
10. Xiang Z, Bugnoli M, Ponzetto A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993;12:739-45.
11. Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. Med Microbiol 1988;26: 93-9.
12. Telford JE, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994;179:1653-8.
13. Tummura MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacler pylori: Evidence of linkage to cytotoxin production. Infect Immun 1993;61:1799-809.
14. Crabtree JE, Figura N, Taylor JD, et al. Expression of 120 kilodalton protein and cytotoxicity in Helicobacler pylori. J Clin Pathol 1992; 45:733-4.
15. Ching CK, Thompson S, Buxton C, et al. Evaluation of a commercial enzyme-linked immunosorbent assay (ELISA) kit for serological diagnosis of Helicobacter pylori infection in a group of non-ulcer dyspepsia sufferers. Postgrad Med J 1993;69:456-60.
16. Ching CK, Buxton C, Holgate C, et al. Cytological brushing urea broth test: A highly sensitive and specific test for Helicobacter pylori infection. Gastrointest Endosc 1991;37:550-1.
17. Hui WM, Lam SK, Chau PY, et al. Pathogenetic role of Campylobacter in gastric ulcer. J Gastroenterol Hepatol 1987;2:309-16.
18. Leunk RD. Production of a cytotoxin by Helicobacter pylori. Rev Infect Dis 1991;13(suppl 8):S686-9.
19. Tricottet V, Bruneval P, Vire O, et al. Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: An ultrastructural study. Ultrastruct Pathol 1986; 10:113-26.
20. Wyatt JI, Rathbone BJ, Dixon MF, et al. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987;40:841-8.
21. Cover TL, Reddy LY, Blaser MJ. Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin. Infect Immun 1993;61:1427-31.
22. Papini E, Bugnoli M, De Bernard M, et al. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa Cells. Mol Microbiol 1993;7:323-7.
23. Crabtree JE, Wyatt JI, Trejdosiewicz LK, et al. Interleukin 8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:61-6.
24. Xiang ZY, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immunol 1995;63:94-8.
25. Sobala GM, Crabtree JE, Pentrith JA, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991;i:94-6.
26. Patel P, Mendall MA, Khulusi S, et al. Salivary antibodies to Helicobacter pylori: Screening dyspeptic patients before endoscopy. Lancet 1994;344:511-2.